A dental service organization is an acquisition engine with clinical operations attached, and the engine's two failure modes are predictable: paying for the seller's reported profit, which is routinely 30 to 50 percent above what the practice actually earns under new ownership, and leaving the acquired practice on its own systems, fee schedules, and habits for a year or more while the group's reporting averages it into everything else. The underwriting and the integration are one discipline, and the integration cost belongs in the price.
What does normalizing a dental practice's earnings involve?
The seller's profit is the starting point, not the number. Owner-dentist compensation replaced with market compensation for the clinical production the seller performs — because a seller taking US$180,000 while producing US$1.1 million is earning less than the group will pay an associate to produce the same; management and administrative work the seller does, priced at the cost of a practice manager if the group will need one; personal expenses run through the practice — vehicles, travel, family payroll, personal insurance — removed; related-party rent reset to market; and cash-basis timing corrected to accrual, which in dental practices means recognizing production when performed and reserving for the insurance and patient receivables the seller never recorded.
Receivables, supplies, and lab work in process. The seller's accounts receivable at a realistic collection rate by age and payer; supply inventory at cost, often overstated by sellers who stocked up; and crowns and appliances at the lab that will be delivered and billed after close — each either valued in the price or excluded from it, but never ignored.
Capital expenditure the seller deferred. Operatory equipment, imaging, and software that the group will replace in year one are a cost of the acquisition; a practice with a fifteen-year-old panoramic unit and three operatories on original chairs carries US$150,000 to US$300,000 of near-term capital that the seller's earnings do not reflect.
How are the doctor's continuation and the hygiene book valued?
The selling doctor's production is the revenue. If the seller leaves at close, the practice's restorative production leaves with them until a replacement is recruited, credentialed, and accepted by patients — six to twelve months of reduced production; if the seller stays two to three years under an employment agreement with a defined transition, production continues and patients transfer to the successor gradually. The price should differ materially between the two cases, and the agreement should pay for the continuation that is actually promised: a base, a production component on net production, and an earn-out or holdback tied to retained production and patient retention at twelve and twenty-four months.
The hygiene book is the asset that transfers. Active patients on recall — seen within eighteen months, with a re-care appointment scheduled or due — are the practice's recurring base and the source of its restorative diagnoses; the count, the recall compliance rate, and the share with insurance plans the group participates in are the underwriting inputs; a practice with 2,400 active patients at 65 percent recall compliance is a different asset from one with 2,400 charts and 35 percent compliance, and the price should know the difference.
Plan participation alignment. The share of the seller's production under plans the group does not participate in, and the retention assumption for those patients when the group's participation applies — because a practice built on two plans the group has exited is a practice whose revenue will fall after close by design.
How is the price structured to protect the buyer?
Cash at close for the normalized earnings the buyer is confident of. A multiple applied to normalized earnings after the integration cost and the deferred capital are reflected, with the multiple set by the group's own cost of capital and the practice's risk profile — location, doctor dependence, plan alignment, equipment condition.
Earn-out or holdback for the earnings that depend on the seller. A portion of the price paid at twelve and twenty-four months against retained net production and active-patient retention, with the metrics defined so they cannot be gamed — net production, not gross; active patients by the group's definition; measured from the group's systems after cutover.
Rollover equity where the seller will stay and lead. A share of the price taken as equity in the group, aligning the seller with the platform's outcome; modeled for its dilution and for the seller's understanding of what they are being offered.
What happens in the sixty-day integration?
Days one to ten: control of the money and the data. Bank accounts, merchant processing, and payroll moved to the group's entities; the seller's practice management system data extracted and mapped — patients, charts, recall status, insurance, open treatment plans, receivables; the group's chart of accounts applied to the practice's ledger from day one; and the acquired practice reported as its own profit-and-loss line from the first month, never merged into a location it does not belong to.
Days ten to thirty: systems and fee schedules. Cutover to the group's practice management and imaging systems in one planned migration with a verification of patient count, open treatment, and recall; the group's fee schedule applied; plan participation aligned with patient notification where the group's participation differs; billing moved to the group's function with the seller's open claims worked to closure; and credentialing of the retained doctor and any new providers submitted on day one.
Days thirty to sixty: operations and people. Staff onboarded to the group's compensation, benefits, and policies with the retention conversations that matter — the office manager and lead hygienist are the two people whose departure costs the most; the group's scheduling templates, re-care program, and case-acceptance process installed; supplies moved to the group's vendor program; and the first monthly management report for the practice delivered on the group's calendar.
What integration costs, and why it belongs in the price. Systems migration and licenses, staff retention bonuses, the office manager's time, the billing transition, patient communication, signage and marketing, deferred capital, and the production dip during cutover — typically US$60,000 to US$150,000 for a single-location practice plus the deferred capital, and it is a cost of the acquisition the underwriting should carry.
Why must same-store and acquired growth be reported separately?
Consolidated growth hides whether the strategy works. A group that reports 28 percent revenue growth after three acquisitions may have grown its existing practices 2 percent and bought the rest; a sponsor or lender will separate the two in diligence, and the group should separate them first: same-store revenue, production, net production, hygiene re-care rate, and contribution for practices owned more than twelve months; acquired-practice performance against the deal model for each acquisition until it crosses the twelve-month line; and synergy realization — supply savings, billing efficiency, plan renegotiation — tracked against what the deal model promised.
Why is this CFO work?
The normalization requires the seller's books rebuilt on an accrual basis with market compensation; the hygiene-book and continuation valuation requires practice management data read against retention assumptions; the price structure is a financial design; the integration is a sixty-day project with cash and systems at its center; and the same-store reporting is the discipline that tells the owners and the sponsor whether the engine is working. The clinical leadership owns the doctor transition and the patient experience; the CFO owns everything that decides whether the group paid the right price and got what it paid for.
Worked example
A regional dental group acquiring a two-doctor, five-operatory practice with US$2.1 million in reported collections and US$520,000 in reported profit; the selling doctor produces US$1.2 million and wants to stay two years.
| Normalization | Amount |
|---|---|
| Reported profit (cash basis) | US$520,000 |
| Seller clinical compensation at market (replaces US$160,000 draw) | −US$190,000 |
| Practice-manager role the seller performs (0.6 of a manager) | −US$42,000 |
| Personal expenses (vehicle, travel, family payroll) | +US$38,000 |
| Related-party rent reset to market | −US$24,000 |
| Receivables reserve (never recorded; 5% of trailing collections) | −US$105,000 one-time; −US$12,000 run-rate |
| Deferred capital (chairs, panoramic unit, software) | US$210,000 one-time |
| Integration cost | US$95,000 one-time |
| Normalized run-rate earnings | US$290,000 |
Illustrative figures for a hypothetical organization; not a client's data.
The seller had been offered a price based on US$520,000; the group's underwriting produced US$290,000 of run-rate earnings and US$410,000 of one-time cost and capital. The structure: cash at close on a multiple of US$290,000 less a portion of the one-time items; a two-year employment agreement for the seller at market base with net-production incentive; 20 percent of the price as a holdback paid at months twelve and twenty-four against retained net production of at least 90 percent and active-patient retention of at least 85 percent; and a small rollover equity component. Integration completed in fifty-four days — cutover on day 22 with a 2,310-patient verification, fee schedule and plan alignment on day 24 with 140 patients notified of a plan change, office manager and lead hygienist retained with twelve-month bonuses. First-year result against the deal model: net production 94 percent of plan, active patients 88 percent retained, supply savings of US$31,000 against US$28,000 modeled, and the holdback paid in full at month twelve.